A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study to Evaluate the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Ulcerative Colitis
收藏DataCite Commons2026-04-27 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00009780/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The objective of this study is to evaluate the efficacy and safety of upadacitinib compared
to placebo in inducing clinical remission (per Adapted Mayo score) in participants with
moderately to severely active ulcerative colitis (UC).
提供机构：
Vivli
创建时间：
2024-01-23
